Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

XGN

Exagen (XGN)

Exagen Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:XGN
DateTimeSourceHeadlineSymbolCompany
12/12/20245:00PMEdgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:XGNExagen Inc
12/12/20249:00AMGlobeNewswire Inc.Exagen Inc. Achieves Key Milestone with 1,000,000th Patient Tested by AVISE® CTDNASDAQ:XGNExagen Inc
11/27/20244:18PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XGNExagen Inc
11/19/20247:24PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XGNExagen Inc
11/18/20246:32PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XGNExagen Inc
11/14/20244:30PMGlobeNewswire Inc.Exagen Inc. Completes Validation and Regulatory Submission for New Lupus and Rheumatoid Arthritis Biomarkers on the AVISE® CTD PlatformNASDAQ:XGNExagen Inc
11/13/20244:05PMGlobeNewswire Inc.Exagen Inc. to Participate in Fourth Quarter Investor ConferencesNASDAQ:XGNExagen Inc
11/12/20248:00AMGlobeNewswire Inc.Exagen Inc. Reports Third Quarter 2024 ResultsNASDAQ:XGNExagen Inc
10/29/20244:05PMGlobeNewswire Inc.Exagen to Announce Third Quarter 2024 Results on November 12, 2024NASDAQ:XGNExagen Inc
10/21/20244:05PMGlobeNewswire Inc.Exagen Announces Acceptance of Five Abstracts at 2024 American College of Rheumatology ConvergenceNASDAQ:XGNExagen Inc
10/08/20244:39PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:XGNExagen Inc
09/04/20246:12PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:XGNExagen Inc
09/04/20246:12PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XGNExagen Inc
09/04/20244:05PMGlobeNewswire Inc.Exagen Inc. to Participate in the 2024 Cantor Global Healthcare ConferenceNASDAQ:XGNExagen Inc
08/09/20245:08PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:XGNExagen Inc
08/05/20249:15AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:XGNExagen Inc
08/05/20248:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:XGNExagen Inc
08/05/20248:00AMGlobeNewswire Inc.Exagen Inc. Reports Strong Second Quarter 2024 Results: Raises Guidance due to Record PerformanceNASDAQ:XGNExagen Inc
08/02/20245:20PMEdgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:XGNExagen Inc
08/02/20249:00AMGlobeNewswire Inc.Exagen Inc. to Participate in the Canaccord Genuity 44th Annual Growth ConferenceNASDAQ:XGNExagen Inc
08/02/20248:15AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:XGNExagen Inc
08/01/20249:00AMGlobeNewswire Inc.Exagen Appoints Jeffrey G. Black as New Chief Financial OfficerNASDAQ:XGNExagen Inc
07/22/20249:00AMGlobeNewswire Inc.Exagen to Announce Second Quarter 2024 Results on August 5, 2024NASDAQ:XGNExagen Inc
06/12/20244:07PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XGNExagen Inc
06/12/20244:06PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XGNExagen Inc
06/12/20244:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XGNExagen Inc
06/11/20244:08PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:XGNExagen Inc
05/16/20248:02PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XGNExagen Inc
05/14/20244:25PMAllPennyStocks.comHealthcare Shares Soar Following Major Price Target IncreaseNASDAQ:XGNExagen Inc
05/13/20249:30AMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:XGNExagen Inc
 Showing the most relevant articles for your search:NASDAQ:XGN

Your Recent History

Delayed Upgrade Clock